Toragen, Inc. · 2 days ago
Scientist I
San Diego, CA
Full-time
Onsite
Mid Level
3+ years expToragen, Inc. is a clinical-stage oncology company focused on the treatment of HPV-induced cancers. They are seeking a highly motivated Scientist to join their drug discovery team, responsible for designing and executing in vitro studies related to immuno-oncology and virology.
Biotechnology
Hiring Manager
Whitney Bullard, Ph.D.
Responsibilities
Design, execute, and interpret in vitro experiments to characterize compound activity and investigate biological mechanisms of action
Perform hands-on cell and molecular biology experiments, including flow cytometry, cell proliferation and viability assays, Western blotting, qPCR, and ELISA., and flow cytometry
Develop, optimize, and troubleshoot biochemical and cell-based assays to evaluate small-molecule compounds
Analyze and synthesize experimental data to guide discovery and translational research strategies
Present experimental results and project updates at internal team meetings and contribute to cross-functional discussions
Qualification
Required
PhD in biochemistry, cell biology, cancer biology, pharmacology, or a related discipline with 2–80-2 years of relevant academic and/or industry experienceindustry or postdoctoral experience; or MS with 7+ years.3-6 years industry or equivalent research experience
Strong background in cell and molecular biology, including mammalian cell culture and assay development
Demonstrated ability to independently design experiments, analyze data, and draw biologically meaningful conclusions
Excellent communication skills and the ability to work effectively in a collaborative, interdisciplinary team environment
Highly motivated, adaptable, and eager to learn new technologies while contributing across multiple projects
Preferred
Experience with cancer biologyimmuno-oncology, translational research, or and biomarker development is highly desirable
Company
Toragen, Inc.
Toragen is focused on developing novel immunotherapies to treat viral-associated cancers.
2-10 employees
Funding
Current Stage
Early StageTotal Funding
$17.4MKey Investors
Bill & Melinda Gates FoundationScott Rasgon,Steven LebowPaul Engler
2025-10-29Grant
2025-09-30Debt Financing· $12M
2022-09-30Seed· $5.4M
Leadership Team
Cheryl Collett, CPA
Chief Financial Officer
Neil Clendeninn
Chief Medical Officer
Recent News
Morningstar.com
2025-10-01
2025-05-04
Company data provided by crunchbase